ARCHIVES

FCRC Recompetition To Be Split Into Two Major Contract, For Research And “Everything Else”

This article is from The Cancer Letter archive.

Vol. 06 No. 35 | September 5, 1980

Download PDF Visit The Full Archive

Related Articles

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

March 8, 2002

House Approves 1.9 Percent Increase For NIH.

July 20, 2007

Phase II Study Of Pfizer Drug Meets Primary Endpoint

April 24, 2009

NCI To Fund Approximately 850 Competing Grants In Fiscal 1986 Under Latest Budget Projections

February 28, 1986

In Brief: Susan Braun Named CEO, Komen Foundation; NCCF Research Fellowship Honors Norman

July 12, 1996

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

February 25, 2011